About Reventek
Reventek is a Santa Clarita, California holding company that builds, acquires and grows research driven brands in personal care, nutraceuticals and medical technology.
Our story
Reventek was founded in December 2023 by Adam Geller around a single question: what would a supplement look like if it were designed from the molecular targets of a studied therapy rather than from a marketing trend? That work became NEUROmergence, the first major product from MDS Labs.
The portfolio grew from there. MDS Labs expanded into a full line of supplements and topical skin care. MDS Research became the home for the portfolio’s published research. In 2024 Reventek acquired MCS Haircare and moved its equipment to the company’s Valencia facility.
Personal care sits at the center of the portfolio, built on its founder’s more than 25 years in skin care and haircare. Each brand speaks to its own customers. Reventek gives all of them the same foundation in research, sourcing, formulation and distribution.
What we believe
Every product starts in the published literature, and every claim is held to what the research actually shows.
We read past the abstract and connect studies to each other, so people get a clear and usable picture.
Discoveries matter most when people can actually get the compounds and understand why they are worth taking.
Ingredients are standardized and authenticated before they reach a formula. Good science deserves good raw materials.
We use AI to read more research, faster, and we check every finding against the original studies.
Cleaner formulas, efficient products and traceable sourcing are requirements, not extras.
Leadership
President and CEO
Adam Geller founded Reventek and leads its research direction, product development and portfolio strategy. He brings more than 25 years of experience in the skin care and haircare industry, along with a successful career in consumer electronics marketing and later work in economic development and municipal marketing.
A background in electrical engineering and hands-on expertise in raw material authentication shape every formula the portfolio produces.
Adam directs the MDS Research program, including its work on cellular senescence, kinase target mapping and the translation of traditional medicine into evidence-based formulations.
How the portfolio works
Reventek centralizes the work that is expensive for a single brand to do well, and lets each brand focus on its customers.
Work with us
We are always interested in companies, researchers and distributors who share our standards.